Trial intelligence / Profile preview

Bioequivalence study of tadalafil 20 mg film-coated tablets in healthy Thai male volunteers

TCTR20170112003Phase 1Terminated

Sponsor
International Bio Service
Start
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of tadalafil (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax and AUC0-72. Started Nov 2017; status: terminated.

02

Drugs

tadalafil

Beyond the preview

Go deeper on TCTR20170112003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170112003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call